Balance Sheet Data

AbbVie Inc. (ABBV)

$165.08

-0.32 (-0.19%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 9,7898,06139,9248,4799,83028,921.7234,563.3541,305.4649,362.7158,991.66
Total Cash (%)
Account Receivables 5,0885,3845,4288,8229,97711,793.3214,093.7916,84320,128.4824,054.85
Account Receivables (%)
Inventories 1,6051,6051,8133,3103,1283,872.554,627.955,530.706,609.557,898.84
Inventories (%)
Accounts Payable 1,4741,5461,4522,2762,8823,278.223,917.694,681.895,595.166,686.59
Accounts Payable (%)
Capital Expenditure -529-638-552-798-787-1,158.46-1,384.43-1,654.49-1,977.22-2,362.91
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.